Trinovium Signs First Commercial Pilot Contract for AI Data Center Cooling
TRIB is trading near its 52-week low of $7.94 (14% above the low) on light trading volume (0.2× avg).
Summary
Trinovium, Trinity Biotech's liquid cooling subsidiary, signed a contract with Red Team Investments (RTI) to develop and deploy direct-to-chip cooling for AI and modular data centers. RTI will be a commercial pilot customer, paying for product supply during the pilot. This is the first revenue-generating validation for Trinovium since its June launch, moving it from concept to real-world deployment. The deal provides operating data and customer feedback to support broader commercialization. Given Trinity Biotech's going concern uncertainty and Nasdaq delisting risk, this contract is a modest but tangible step toward a new revenue stream. Watch for pilot results and any follow-on commercial orders.
At the time of this announcement, TRIB was trading at $9.06 on NASDAQ in the Technology sector, with a market capitalization of approximately $5.8M. The 52-week trading range was $7.94 to $52.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.